The PathMaker Program definitely had a significant impact on my career path. It was what opened the door to the research world and provided me with the support I needed...
Every day at Huntsman Cancer Institute (HCI), members of our more than 200 cancer research teams enter the doors with a strong sense of responsibility to make a difference in...
Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Courtney Scaife, MD, was recently honored with a...
Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Benjamin L. Maughan, MD, PharmD, was recently honored...
To say that the PathMaker Program made an impact on my life would be a huge understatement. I learned so much from my PathMaker experience, I honestly could write a...
Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Randy Jensen, MD, PhD, was recently honored with...
A study by KT Varley, PhD, aims to improve treatments for triple-negative breast cancer patients. Findings could be used to determine who could safely be treated with less aggressive therapy.
In 2018, a team of researchers at Huntsman Cancer Institute received a prestigious National Cancer Institute Cancer Moonshot grant. The grant will fund studies about ways to identify patients who...
In summer 2018, Huntsman Cancer Institute established a Community Advisory Board (CAB) to increase community outreach and engagement and address health disparities through collaboration. The 38 CAB members represent government...
